GARY BRONSTEIN

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease ROSEBURG, OR NPI 1932284528

General Payments — all program years on this page

$2,701.62

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 168
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $517.79 across 37 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $517.7937

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $519.7632
2019 $762.9951
2020 $275.5318
2021 $99.125
2022 $129.057
2023 $397.3818
2024 $517.7937

Records — PY2024 (37)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080605577 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.38 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080605696 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.55 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080605758 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.38 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694459 Novartis Pharmaceuticals Corporation $6.36 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694461 Novartis Pharmaceuticals Corporation $13.50 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694463 Novartis Pharmaceuticals Corporation $2.14 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694465 Novartis Pharmaceuticals Corporation $3.78 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694469 Novartis Pharmaceuticals Corporation $17.33 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694473 Novartis Pharmaceuticals Corporation $8.18 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694475 Novartis Pharmaceuticals Corporation $8.26 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694477 Novartis Pharmaceuticals Corporation $3.17 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694479 Novartis Pharmaceuticals Corporation $3.13 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694481 Novartis Pharmaceuticals Corporation $12.80 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694483 Novartis Pharmaceuticals Corporation $5.53 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694485 Novartis Pharmaceuticals Corporation $2.57 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694491 Novartis Pharmaceuticals Corporation $32.98 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694519 Novartis Pharmaceuticals Corporation $13.25 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694527 Novartis Pharmaceuticals Corporation $3.61 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694529 Novartis Pharmaceuticals Corporation $3.21 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694531 Novartis Pharmaceuticals Corporation $6.78 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694537 Novartis Pharmaceuticals Corporation $32.98 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086694541 Novartis Pharmaceuticals Corporation $14.43 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096644464 Novo Nordisk Inc $17.83 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096968761 Novo Nordisk Inc $19.34 06/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097769688 Novo Nordisk Inc $20.68 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105550198 AstraZeneca Pharmaceuticals LP $14.59 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111537066 Amgen Inc. $26.02 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111537068 Amgen Inc. $14.36 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125343869 Abbott Laboratories $18.77 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129429142 Esperion Therapeutics, Inc. $13.24 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132081170 PFIZER INC. $15.95 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132095665 PFIZER INC. $22.91 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132109487 PFIZER INC. $14.13 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138863151 Edwards Lifesciences Corporation $16.16 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138863153 Edwards Lifesciences Corporation $15.52 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141843333 Merck Sharp & Dohme LLC $17.63 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154887453 Kiniksa Pharmaceuticals International, plc $21.36 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.